The invention provides a compound of formula (I): [Chemical formula should be inserted here. Please see paper copy.] wherein R
1
, R
2
, R
3
, R
3a
, R
4
, R
4a
, R
5
, and R
6
are as defined; or a pharmaceutically acceptable salt thereof or a solvate thereof; compositions containing these compounds, processes for preparing them and their use as modulators of chemokine activity (especially CCR5 activity).
本发明提供了一种化合物,其
化学式为(I):[
化学式应在此处插入。请参阅纸质副本。]其中R1、R2、R3、R3a、R4、R4a、R5和R6如定义;或其药学上可接受的盐或溶剂;含有这些化合物的组合物,制备它们的过程以及它们作为
趋化因子活性(特别是CCR5活性)调节剂的用途。